Search Results - "RAHMANLAR, Hanife"

A Multifaceted Evaluation of National Off-label Neurology Applications by Yurtoğulları, Şükran, Rahmanlar, Hanife, Alkan, Ali, Bayar, Banu, Gürsöz, Hakkı, Uzun Adatepe, Nurten

“…Objective: Off-label drug use (OLDU) of neurologic diseases is approved by a regulatory authority, the Turkish Medicines and Medical Devices Agency (TMMDA) in…”
Get full text

Türkiye’de Diyabetik Retinopati Tanısında Endikasyon Dışı İlaç Kullanımı by Rahmanlar, Hanife, Üçgül Atılgan, Cemile, Çıtırık, Mehmet, Yaradılmış, İbrahim Muaz, Gürsöz, Hakkı

“…Amaç: Türkiye’de diyabetik retinopatisi olan hastalarda endikasyon dışı ilaç kullanımı için yapılan başvuruların demografik özelliklerini değerlendirmek. Gereç…”
Get full text

Türkiye’de Yaşa Bağlı Maküla Dejenerasyonunda Endikasyon Dışı İlaç Kullanımı by RAHMANLAR, Hanife, ÜÇGÜL ATILGAN, Cemile, ÇITIRIK, Mehmet, ALKAN, Ali, GÜRSÖZ, Hakkı

“…Amaç: Türkiye’de yaşa bağlı maküla dejenerasyonu (YBMD) olan hastalarda endikasyon dışı (off-label) ilaç kullanımı için yapılan başvuruların demografik…”
Get full text

Evaluation of off‐label anti‐vascular endothelial growth factor and steroid implant medication uses in macular edema due to retinal vein occlusion in Turkey by Yilmaz, Mevlut, Citirik, Mehmet, Rahmanlar, Hanife, Alkan, Ali, Gursoz, Hakki

“…What is Known and Objective Retinal vein occlusion (RVO) is one of the most common causes of vision loss. Anti‐vascular endothelial growth factor (anti‐VEGF)…”
Get full text

Off-Label uses of ranibizumab and aflibercept for age-related macular degeneration in Turkey by Yilmaz, Mevlut, Citirik, Mehmet, Rahmanlar, Hanife, Alkan, Ali, Gursoz, Hakki

“…Purpose: To evaluate the clinical and demographic aspects of off-label drug use applications for age-related macular degeneration (AMD) in Turkey. Methods:…”
Get full text

Off-label uses of Aflibercept, Ranibizumab and Dexamethasone implant for diabetic retinopathy in Turkey by Yilmaz, Mevlut, Citirik, Mehmet, Rahmanlar, Hanife, Alkan, Ali, Gursoz, Hakki

“…Diabetic retinopathy (DRP) is the most common retinal vascular disease leading to blindness. There is limited data about the off-label drug use for DRP and…”
Get full text

Biological therapy for ocular Behçet’s disease with off-label drug prescription in Turkey by Citirik, Mehmet, Ucgul Atilgan, Cemile, Rahmanlar, Hanife, Alkan, Ali, Gursoz, Hakki

“…ObjectiveThe use of biological agents in the treatment of ocular Behçet’s disease has recently become more frequent. The use of two agents, infliximab (IFX)…”
Get full text

A Multifaceted Evaluation of National Off-label Neurology Applications/Ulusal Endikasyon Disi Noroloji Basvurularinin Cok Yonlu Degerlendirilmesi by Yurtogullari, Sukran, Rahmanlar, Hanife, Alkan, Ali, Bayar, Banu, Gursoz, Hakki, Adatepe, Nurten Uzun

“…Objective: Off-label drug use (OLDU) of neurologic diseases is approved by a regulatory authority, the Turkish Medicines and Medical Devices Agency (TMMDA) in…”
Get full text

Off-Label Drug Use in Patients with Age-Related Macular Degeneration in Turkey by Hanife RAHMANLAR, Cemile ÜÇGÜL ATILGAN, Mehmet ÇITIRIK, Ali ALKAN, Hakkı GÜRSÖZ

“…Aim:To evaluate the demographic characteristics of patients who use off-label drugs for Age-related Macular Degeneration (AMD) in Turkey.Materials and…”
Get full text

Off-Label Drug Use in Ocular Behçet's Disease in Turkey by HANİFE RAHMANLAR, Mehmet Murat uzel, Mehmet Çıtırık, Ali Alkan, Hakkı Gürsöz

“…INTRODUCTION: To assess demographic characteristics in patients with ocular Behçet's disease who use off-label drugs in Turkey. METHODS: The applications for…”
Get full text